In summary, prior experimental studies have already demonstrated that TAMs can directly suppress or reprogram NK cells via contact-dependent mechanisms and soluble mediators, and that molecules such as MIF and SPP1 are implicated in shaping tumor-promoting myeloid phenotypes and inhibiting anti-tumor lymphocyte functions (15, 48, 49). The gene discussed is MIF; the disease is neoplasm.